On The Web![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif){kind=icon}
Site SearchRaleigh, N.C. — Mark Sirgo, chief executive officer at BioDelivery Sciences International (Nasdaq: BDSI), is joining the board of directors at Salix Pharmaceuticals (Nasdaq: SLXP).
Sirgo is a graduate of Ohio State University with a degree in pharmacy. He earned a doctorate at the Philadelphia College of Pharmacy and Science. He has more than 25 years of experience in the pharmaceutical industry.
BDSI, which is based in the Triangle, is developing breakthrough pain treatments.
Salix, which is based in Raleigh, develops and sells a variety of gastrointestinal diseases.
Salix Names BioDelivery Sciences International CEO to Board
Copyright 2009 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Jul. 3, 2009 - As Nortel’s final demise nears, what blame should its board shoulder?
Jul. 3, 2009 - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Jul. 3, 2009 - 20/20: Surgery can let you see like a child again
Jul. 3, 2009 |
- CDC: US swine flu cases rise to nearly 34,000
Jul. 3, 2009
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement